AT290731B - Verfahren zur Herstellung eines ölige oder flüssige, therapeutisch verwendbare Glukofuranoside enthaltenden Granulates - Google Patents

Verfahren zur Herstellung eines ölige oder flüssige, therapeutisch verwendbare Glukofuranoside enthaltenden Granulates

Info

Publication number
AT290731B
AT290731B AT748569A AT748569A AT290731B AT 290731 B AT290731 B AT 290731B AT 748569 A AT748569 A AT 748569A AT 748569 A AT748569 A AT 748569A AT 290731 B AT290731 B AT 290731B
Authority
AT
Austria
Prior art keywords
glucofuranosides
oily
production
liquid
therapeutically useful
Prior art date
Application number
AT748569A
Other languages
German (de)
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT290731B publication Critical patent/AT290731B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT748569A 1968-08-05 1969-08-04 Verfahren zur Herstellung eines ölige oder flüssige, therapeutisch verwendbare Glukofuranoside enthaltenden Granulates AT290731B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1170468 1968-08-05

Publications (1)

Publication Number Publication Date
AT290731B true AT290731B (de) 1971-06-11

Family

ID=4376070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT748569A AT290731B (de) 1968-08-05 1969-08-04 Verfahren zur Herstellung eines ölige oder flüssige, therapeutisch verwendbare Glukofuranoside enthaltenden Granulates

Country Status (23)

Country Link
US (2) US3594474A (enExample)
AT (1) AT290731B (enExample)
BE (1) BE737053A (enExample)
BG (1) BG17466A3 (enExample)
BR (1) BR6911321D0 (enExample)
CA (1) CA938889A (enExample)
CY (1) CY790A (enExample)
DE (1) DE1938108C3 (enExample)
DK (1) DK123912B (enExample)
FI (1) FI50058C (enExample)
FR (1) FR2015053A1 (enExample)
GB (1) GB1259387A (enExample)
IE (1) IE33246B1 (enExample)
IL (1) IL32673A (enExample)
IT (1) IT1035508B (enExample)
MY (1) MY7500079A (enExample)
NL (1) NL162837C (enExample)
NO (1) NO129183B (enExample)
OA (1) OA03604A (enExample)
PL (1) PL88871B1 (enExample)
RO (1) RO57881A (enExample)
SE (1) SE363735B (enExample)
SU (1) SU409407A3 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
DE3773926D1 (de) * 1987-07-22 1991-11-21 Farvalsa Ag Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung.

Also Published As

Publication number Publication date
FR2015053A1 (enExample) 1970-04-24
NO129183B (enExample) 1974-03-11
NL6911864A (enExample) 1970-02-09
SU409407A3 (enExample) 1973-11-30
BE737053A (enExample) 1970-02-04
IL32673A0 (en) 1969-09-25
MY7500079A (en) 1975-12-31
DE1938108A1 (de) 1970-02-26
IE33246L (en) 1970-02-05
DK123912B (da) 1972-08-21
GB1259387A (enExample) 1972-01-05
NL162837C (nl) 1980-07-15
US3594474A (en) 1971-07-20
SE363735B (enExample) 1974-02-04
OA03604A (fr) 1971-03-30
IT1035508B (it) 1979-10-20
IL32673A (en) 1973-11-28
IE33246B1 (en) 1974-05-01
NL162837B (nl) 1980-02-15
CA938889A (en) 1973-12-25
CY790A (en) 1976-06-01
FI50058C (fi) 1975-12-10
DE1938108C3 (de) 1974-01-03
BR6911321D0 (pt) 1973-02-13
RO57881A (enExample) 1974-11-15
US3655870A (en) 1972-04-11
BG17466A3 (bg) 1973-11-10
PL88871B1 (enExample) 1976-10-30
FI50058B (enExample) 1975-09-01

Similar Documents

Publication Publication Date Title
CH533148A (de) Verfahren zur Herstellung von Schaumstoffen
CH544093A (de) Verfahren zur Herstellung von O-Acyl-lysergolen
CH544736A (de) Verfahren zur Herstellung von Bromnitroalkoholen
AT291933B (de) Verfahren zur Herstellung von Magnesium-Alkohol-Verbindungen
AT320376B (de) Verfahren zur Herstellung von Metallflocken
CH456500A (de) Verfahren zur Herstellung von Stahlrohren
CH475923A (de) Verfahren zur Herstellung homöoporöser Kohlenstoffkörper
CH543553A (de) Verfahren zur Herstellung von Poly-amid-imid-estern
CH521294A (de) Verfahren zur kontinuierlichen Herstellung von Acetylenalkoholen
AT287889B (de) Verfahren zur Herstellung enzymhaltiger Granulate
CH503681A (de) Verfahren zur Herstellung von Dihydrocarvon
AT296952B (de) Kontinuierliches Verfahren zur Herstellung von Adiponitril
AT298814B (de) Verfahren zur Herstellung von Schaumstoffen
AT266042B (de) Verfahren zur Herstellung von Graphitkörpern
AT290731B (de) Verfahren zur Herstellung eines ölige oder flüssige, therapeutisch verwendbare Glukofuranoside enthaltenden Granulates
CH516493A (de) Verfahren zur Herstellung von Tetrachlorkohlenstoff
CH551373A (de) Verfahren zur herstellung von bronchospasmolytisch wirksamen verbindungen.
AT300840B (de) Verfahren zur Herstellung von Organo-H-silanen
CH544808A (de) Verfahren zur Herstellung von Negamycin
CH543487A (de) Verfahren zur Herstellung von Adamantylharnstoffen
AT301504B (de) Verfahren zur Herstellung von Alkoholen
AT290501B (de) Verfahren zur Herstellung von Thiophenolen
CH497425A (de) Verfahren zur Herstellung von B-Picolin
CH504530A (de) Verfahren zur Herstellung von Cytidin-diphosphat-cholin
CH544758A (de) Verfahren zur Herstellung von Lysergolen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee